Zoster Vaccine Response in the Frail Elderly

Status Completed

Clinical Trial Summary

This study is being done to evaluate the zoster vaccine response in the nursing home elderly (80 years or older). As the immune system ages, the response to vaccines is not always as strong as in younger people. Previous zoster vaccine studies have excluded nursing home residents so the vaccine effect in this population is not known. Furthermore, the immune and genetic reasons as to why the vaccine works well in some people but not in others are also unknown. The goal of this study is to evaluate why some immune systems respond well to the vaccine and why others do not.

Clinical Trial Description

Deleterious changes in immunity that occur with aging are known as immunosenescence. Such changes, particularly in adaptive immunity, may lead to an impaired vaccine response in the elderly. Characterizing the immune determinants and the genetic basis for vaccine response in the frail elderly is a practical approach to better our understanding of immunosenescence. Data on genetic determinants to immunization are sparse, furthermore, to the best of our knowledge, none exist in the elderly. In this pilot study, we propose studying the immune response to the herpes zoster vaccine and the underlying genetic determinants of the immune response in elderly residents of nursing homes.

The three specific aims of this study are to generate data in order to 1) assess the T-cell response to the varicella-zoster virus (VZV) vaccine in the frail elderly; 2) assess whether immune (T-cell) phenotypes are associated with a response; 3) test the association between immune response genotype sets and T-cell response. We hypothesize that response to the VZV vaccine in elderly nonambulatory nursing home residents is a function of characteristic T-cell immune phenotypes prior to vaccination and that there are immune genetic polymorphisms associated with the response. This study will allow us to generate preliminary data and establish feasibility in order to address these questions fully in a larger population in a subsequent grant application. ;

Study Design

Related Conditions & MeSH terms

Immune System Diseases

Clinical Trial Details

NCT number	NCT01328548
Study type	Observational
Source	McMaster University
Contact
Status	Completed
Phase
Start date	May 2011
Completion date	March 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03663933` - Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation	Phase 2
Completed	`NCT03563066` - Effect of Benralizumab in Atopic Dermatitis	Phase 2
Recruiting	`NCT04339777` - Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity	Phase 2
Not yet recruiting	`NCT05969821` - Clonal Hematopoiesis of Immunological Significance
Completed	`NCT02916888` - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists	N/A
Completed	`NCT02527187` - Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa	Phase 2
Completed	`NCT01441076` - Anakinra for Behcet s Disease	Phase 1/Phase 2
Completed	`NCT01472263` - Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases	Phase 3
Completed	`NCT03720470` - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	Phase 3
Suspended	`NCT04642066` - Cold Water Immersion and Atherosclerosis, Inflammation, Fat Accumulation and Lipid Profile Parameters	N/A
Completed	`NCT02294552` - Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT	Phase 2
Completed	`NCT01727973` - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy	Phase 1/Phase 2
Completed	`NCT04103099` - Impact of HLNatural Immune Supplement on Colds	N/A
Recruiting	`NCT03344094` - Mechanism of Action of Ocrelizumab in Multiple Sclerosis	N/A
Active, not recruiting	`NCT05445284` - Group Education Trial to Improve Transition for Parents of Adolescents With T1D	N/A
Recruiting	`NCT06104111` - Epigenetic Memory of Vitamin D Supplementation	Phase 1
Not yet recruiting	`NCT05616117` - Next-generation Effects of Vitamin D Supplementation in Pregnancy
Completed	`NCT01510626` - Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center	Phase 1
Completed	`NCT01490177` - Single Center Food Allergy Oral Immunotherapy Study	Phase 1
Completed	`NCT03922087` - No-worry Baby Project